Medpace (MEDP) EVP Susan Burwig Exercises Stock Options

What Happened

• Susan E. Burwig, Executive Vice President, Operations at Medpace Holdings, exercised option(s) on September 15, 2026. The filing reports the acquisition of 3,000 shares at an exercise price of $166.73 per share (total cost ~$500,190).
• The same filing also reports a disposition of 3,000 derivative shares at $0.00 (reported as a derivative disposition). Both transactions are coded M (exercise or conversion of derivative securities). The filing does not show sale proceeds for the disposition.

Key Details

• Transaction date: 2026-09-15
• Acquired: 3,000 shares @ $166.73; total $500,190
• Disposed: 3,000 shares @ $0.00 (reported as derivative disposition)
• Footnote: The option vested in full on October 27, 2025 (F1).
• Shares owned after transaction: Not stated in the provided excerpt.
• Filing: Form 4 filed 2026-09-17 (filed within the normal Form 4 window; not marked late).
• Transaction code: M = exercise or conversion of a derivative security.

Context

• This was an option exercise (derivative transaction), which results in the insider acquiring company stock by converting options. The reported 3,000-share disposition at $0.00 may reflect shares withheld to cover exercise costs or taxes or another non-cash transfer, but the filing does not specify the reason or any market sale. Such exercises are often routine and do not by themselves indicate the insider’s view of the company’s stock price.